Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
AVLN Pre-Tax Margin
Income before tax as a percentage of revenue.
No reported Pre-Tax Margin figures are available to summarize.
Pre-Tax Margin history
Percent of revenue · from the income statement
No Pre-Tax Margin data reported for this period type.
Pre-Tax Margin vs competitors
How AVLN compares with its peers on the latest reported figures
AVLN Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 0.5% | -14.8 pp | +3.2 pp | |
| LTM Mar 2026 | -7.9% | -19.1 pp | +88.0 pp | |
| LTM Jun 2026 | -76.4% | +182.3 pp | -14.0 pp | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | -20481.7% | -7787.4 pp | — |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — |
| Peer median (excluding AVLN) | -42.2% | -16.9 pp | +3.2 pp | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.